Sequential High‐Dose Ruxolitinib and Low‐Dose Splenic Irradiation for Pretransplant Management of Splenomegaly Before Allogeneic Hematopoietic Cell Transplantation With Fludarabine/Busulfan‐Based Conditioning in Myelofibrosis
Peng Ke, Chun Feng, Guoqiang Li, Xiaoyong Chen, Yixuan Cao, Lina Hu, Jiahe Zhang, Linlin Wang, Jihao Zhou · 2026
Read Sequential High‐Dose Ruxolitinib and Low‐Dose Splenic Irradiation for Pretransplant Management of Splenomegaly Before Allogeneic Hematopoietic Cell Transplantation With Fludarabine/Busulfan‐Based Conditioning in Myelofibrosis by Peng Ke, Chun Feng, Guoqiang Li, Xiaoyong Chen, Yixuan Cao, Lina Hu, Jiahe Zhang, Linlin Wang, Jihao Zhou (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13500039.txt.
Description
Peng Ke and eight co-authors read past cases of a two-step plan to shrink a vast spleen ahead of a stem-cell graft in a marrow scar ill. Their study, from two thousand twenty-six, covers a span of years at one center.
A huge spleen is a chief bar to grafts in this ill: it slows the graft's take and risks its fail. A vein-drug that blocks a growth path, and low rays to the spleen, are each used alone. Proof for their use in chain, in a modern prep plan, was thin. Nine patients got the chain: high-dose drug first, then low rays. All went on to the graft. The team reads how the plan held.
Catalog record
| CREATOR | Peng Ke, Chun Feng, Guoqiang Li, Xiaoyong Chen, Yixuan Cao, Lina Hu, Jiahe Zhang, Linlin Wang, Jihao Zhou |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |